<p>Six proteomic clocks detect a younger biological age signal in an IPF trial – but separating geroprotection from treatment remains key. Six proteomic clocks, six different research pedigrees, one direction of travel: that is the headline finding of a new study in Nature Biotechnology, and it is arre</p>